Chronic Obstructive Pulmonary Disease News and Research RSS Feed - Chronic Obstructive Pulmonary Disease News and Research

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
Researchers explain why people with asthma have hard time dealing with respiratory viruses

Researchers explain why people with asthma have hard time dealing with respiratory viruses

People with asthma often have a hard time dealing with respiratory viruses such as the flu or the common cold, and researchers have struggled to explain why. [More]
New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma patients

New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma patients

Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma®) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma. [More]
LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to Washington state for-profit and non-profit organizations to promote translation of health-related technologies from the laboratory to the commercial marketplace. [More]
Professor receives grant from NIH to test effects of high-intensity functional training

Professor receives grant from NIH to test effects of high-intensity functional training

Katie Heinrich, assistant professor of kinesiology at Kansas State University, has been awarded an investigator-initiated grant from the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases for more than $2.52 million. [More]

Dyspnoea in COPD patients heralds worse outcomes

Breathlessness is a common finding in patients with chronic obstructive pulmonary disease and signals an increased risk of exacerbations, study findings indicate. [More]
CAT score useful for predicting COPD exacerbations

CAT score useful for predicting COPD exacerbations

The likelihood and imminence of a chronic obstructive pulmonary disease exacerbation in high-risk patients could be predicted using the COPD assessment test score, study findings indicate. [More]
Distinct features of COPD–asthma overlap syndrome identified

Distinct features of COPD–asthma overlap syndrome identified

US researchers have shown that patients with both chronic obstructive pulmonary disease and asthma have more exacerbations, less emphysema and more airway disease than patients with COPD alone. [More]
Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows. [More]
Biochemists discover proteins that could lead to better treatments for life-threatening infections

Biochemists discover proteins that could lead to better treatments for life-threatening infections

Two Kansas State University biochemists have discovered a family of proteins that could lead to better treatments for Staphylococcus aureus, a pathogenic bacterium that can cause more than 60,000 potentially life-threatening infections each year. [More]
BreathingSpace health facility improves quality of life for people with severe respiratory disease

BreathingSpace health facility improves quality of life for people with severe respiratory disease

A unique national health pilot supported by the Coalfields Regeneration Trust, has provided a radical step change in improving the quality of life for people in Rotherham with severe respiratory disease, with reported deaths from bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD) now 30% lower than the national average just 6 years after its opening. [More]
Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Mortality and morbidity of atrial fibrillation (AF) patients remains high at one year despite good use of oral anticoagulants, according to the one year follow up of the Atrial Fibrillation General Pilot Registry. [More]
Boehringer Ingelheim announces FDA acceptance of NDA filing for tiotropium and olodaterol FDC

Boehringer Ingelheim announces FDA acceptance of NDA filing for tiotropium and olodaterol FDC

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration accepted for review the New Drug Application (NDA) for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the Respimat inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. [More]

Umeclidinium/vilanterol outperforms monotherapies in COPD

A combination of umeclidinium and vilanterol is more effective than each drug as monotherapy for the treatment of chronic obstructive pulmonary disease, research indicates. [More]
COPD overlooked in cardiovascular patients

COPD overlooked in cardiovascular patients

More than a quarter of patients with cardiovascular disease and a history of smoking also have air flow limitation compatible with chronic obstructive pulmonary disease, Japanese study data show. [More]
Researchers identify predictors of early rehospitalization among patients with COPD

Researchers identify predictors of early rehospitalization among patients with COPD

Researchers at the University of Texas Medical Branch at Galveston have identified predictors of early rehospitalization among patients hospitalized for complications of chronic obstructive pulmonary disease. This study was recently published in the Annals of the American Thoracic Society. [More]
Trends and developments of the global ventilators market

Trends and developments of the global ventilators market

Ventilators Market To 2020 - Technical Advances And Hospital Expansion Serve As Distinct Regional Growth Drivers [More]
TAXIS acquires novel antimicrobial drug candidates from Biota

TAXIS acquires novel antimicrobial drug candidates from Biota

TAXIS Pharmaceuticals, Inc. today announced the acquisition of a group of novel antimicrobial drug candidates from Biota Pharmaceuticals Inc. of Atlanta, GA. [More]
Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. [More]
Comprehensive database collecting information about microRNAs, multiMiR

Comprehensive database collecting information about microRNAs, multiMiR

Your genes are blueprints for proteins, and molecules called microRNA can help to determine how often these genetic blueprints are manufactured into proteins. Researchers often ask what microRNA regulates a gene related to disease. [More]
Diabetes linked to increased head and neck cancer risk

Diabetes linked to increased head and neck cancer risk

People with diabetes mellitus have a significantly increased risk of developing head and neck cancer compared with those without the condition, show results of a large study conducted in Taiwan. [More]